LH
33
3
SRE
37
9
VNO
46
6
FTI
61
5
CA
19
6
ABT
54
4
DVA
62
5
CMI
49
2
M
40
3
MDLZ
28
2
CNX
67
4
BAC
38
3
NSC
33
6
ROK
46
3
IP
53
3
SWK
53
4
DG
14
6
CAG
34
3
CHRW
53
2
EXPD
29
2
LH
33
3
SRE
37
9
VNO
46
6
FTI
61
5
CA
19
6
ABT
54
4
DVA
62
5
CMI
49
2
M
40
3
MDLZ
28
2
CNX
67
4
BAC
38
3
NSC
33
6
ROK
46
3
IP
53
3
SWK
53
4
DG
14
6
CAG
34
3
CHRW
53
2
EXPD
29
2
Financhill
Back

Ionis Pharmaceuticals 10K Form

Sell
45

IONS
Ionis Pharmaceuticals

Last Price:
$35.63
Seasonality Move:
11.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q IONS/Ionis Pharmaceuticals Quarterly
2023-08-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2023-05-03 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-11-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-08-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-05-04 10Q IONS/Ionis Pharmaceuticals Quarterly

Receive IONS News And Ratings

See the #1 stock for the next 7 days that we like better than IONS

IONS Financial Statistics

Sales & Book Value

Annual Sales: $787.6M
Cash Flow: $-111.3M
Price / Cash Flow: 0
Annual Sales: $4.20
Price / Book: 8.49

Profitability

EPS (TTM): -2.44000
Net Income (TTM): $-358.8M
Gross Margin: $778.5M
Return on Equity: -93.21%
Return on Assets: -12.41%

Ionis Pharmaceuticals Earnings Forecast

Key Ionis Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 34 years for IONS is 98.84%.
  • The Selling, General & Administrative Expenses for IONS have been equal to 29.53% of Gross Profit Margin.
  • The Research & Development expenses have been 114.22% of Revenue.
  • The Interest Expense is -20.64% of Operating Income.
  • The Net Earning history of IONS is -46.50% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 16 years.

Ionis Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IONS
CUSIP: 462222
Website: ionispharma.com

Debt

Debt-to-Equity Ratio: 1.93
Current Ratio: 8.91
Quick Ratio: 8.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IONS Technical Analysis vs Fundamental Analysis

Sell
45
Ionis Pharmaceuticals (IONS) is a Sell

Is Ionis Pharmaceuticals a Buy or a Sell?